Aviceda Therapeutics

Operator of a biotechnology company intended to develop breakthrough glycol-therapeutics for patients. The company combines biology with a cell-based screening platform and proprietary nanoparticle te...

Healthcare

Cambridge, MA, United States

Founded 2018

33 employees

Website

Valuation

$346.5M

Market implied

Share Price

N/A

Total Raised

$276.3M

Last Round

N/A

Investors

+12 other investors

View all 12 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Aviceda Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required